Personalis, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Personalis, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $1.41M, a 24.99% decline year-over-year.
- Personalis, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.44M.
- Personalis, Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $915.00K.
- Personalis, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $725.00K.
- Personalis, Inc. stock issued during period, value, new issues for fiscal 2023 was $3.51M.
- Personalis, Inc. stock issued during period, value, new issues for fiscal 2021 was $161.92M, a 38.31% increase from fiscal 2020.
- Personalis, Inc. stock issued during period, value, new issues for fiscal 2020 was $117.06M, a 16.28% decline from fiscal 2019.
- Personalis, Inc. stock issued during period, value, new issues for fiscal 2019 was $139.83M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-06-30 | $1.41M 10-Q · filed 2024-08-07 | $4.48M derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | $1.44M 10-Q · filed 2024-05-08 | $4.95M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-12-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.51M 10-K · filed 2024-02-28 |
| 2023-09-30 | $725.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.87M 10-Q · filed 2024-08-07 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $161.92M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $161.92M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $278.98M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $161.92M 10-Q · filed 2022-05-04 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $117.06M 10-K · filed 2023-02-23 |
| 2020-09-30 | $117.06M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $139.83M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | |
| 2019-06-30 | $140.02M 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |